Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities ...
Dec 6, 2022
0
38
Inequitable access to COVID-19 vaccines has turned out to be the catastrophic moral failure the World Health Organization's director-general warned about at the beginning of 2021.
Aug 30, 2022
0
13
German pharmaceutical company CureVac said Tuesday it was suing rival BioNTech for patent infringement over the mRNA technology used to develop the Comirnaty coronavirus vaccine.
Jul 5, 2022
0
2
Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.
Jan 17, 2022
0
19
A simple RNA molecule jumpstarts the immune system's "first responders" to viral infection and can even eradicate the SARS-CoV-2 virus in mice with chronic cases of COVID-19, a new Yale School of Medicine study finds.
Nov 10, 2021
0
8
A potential new drug candidate developed by researchers at the University of Oulu, Finland, has been granted a patent in the United States. The drug is a small molecular chemical compound that is especially suited for cancer ...
Nov 8, 2021
0
7
Many hopes have been pinned on repurposing existing drugs, such as ivermectin and hydroxychloroquine, to treat COVID-19. However, we shouldn't be too surprised these drugs haven't yet lived up to the hype.
Sep 23, 2021
0
10
(HealthDay)—The highly transmissible Delta variant of COVID-19 has highlighted a fear shared by infectious disease experts worldwide: That increasingly dangerous mutations will continue to crop up until most people around ...
Sep 8, 2021
0
10
The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on COVID-19 vaccines was not a bid to "snatch" their intellecutual property rights.
Jul 22, 2021
0
1
The European Parliament has urged the EU to back a push for a temporary waiver of coronavirus vaccine patents, in the face of scepticism from Brussels and key member states.
May 20, 2021
0
9
